Neurosurgeon Dr. Philip Starr tells MassDevice.com about Medtronic's new Activa PC+S brain monitoring, recording and stimulating implant and its potential for treating neurological and psychiatric disease.
In this MassDevice.com podcast, we speak with Glooko CEO Rick Altinger about the company's mobile diabetes management application for smartphones and how it has the potential to change the spectrum of care for one of the world's most common chronic diseases.
Our teams continue to work on Google Glass applications for Emergency Department workflow improvement. Here's a photo of our team at work with a stealthy startup developing healthcare solutions on Google Glass.
The bipartisan budget deal reached this week includes a provision that would repeal the medical device tax.
The bipartisan deal struck between negotiators in the U.S. House of Representatives and the U.S. Senate includes language that would roll back the 2.3% excise tax on medical device sales.
The deal, hashed out by Rep. Paul Ryan (R-Wis.) and Sen. Patty Murray (D-Wash.), is expected to pass the House today. The agreement would set a 2-year budget through fiscal 2015 and partially repeal portions of the sequester limiting federal spending.
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
The House of Representatives' Energy & Commerce Committee looks into a cybersecurity breach that exposed thousands of active accounts of FDA employees.
MASSDEVICE ON CALL — House Energy & Commerce Committee members are taking a closer look at the FDA following an October hack that exposed thousands of agency employee accounts, including some 5,000 for active users.
The FDA has until December 23 to product documents related to the breach, which tapped employee user-names, passwords, email addresses, phone numbers and more.
Panelists of the FDA's Circulatory Systems Devices Panel vote 13-1 in favor of approving Boston Scientific's Watchman anti-stroke cardiac implant.
The FDA's Circulatory Systems Devices Panel today voted 13-1 to recommend approval of Boston Scientific's(NYSE:BSX) Watchman 1st-of-its-kind left atrial appendage (LAA) closure device for reducing the risk of stroke and systemic embolism.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.